Baxter Biopharma Solutions, Drug Manufacturers, Medical Devices, Regulation, Sponsored, Technology, Therapy Area

Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility

By Baxter BioPharma Solutions

Manufacturing in multi-product facilities affords numerous advantages but also presents significant challenges. At its Halle / Westfalen, Germany, plant, Baxter BioPharma Solutions has implemented a risk-based approach to addressing those challenges, providing customers with the benefits of multiproduct manufacturing. The biopharmaceutical industry is continually challenged to reduce costs and the time needed to produce advanced drug products. Drug manufacturers are consequently pursuing numerous approaches to achieving gains in efficiency and productivity.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sections

Sections

Sections

Sections

Sections